Close Menu
    What's Hot

    Editor’s Letter – Volume 2, Issue 4, April 2026

    April 9, 2026

    Life Settlement Market Faces Contrasting Views on Term Life Policy Conversions

    April 9, 2026

    Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

    April 9, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Tailwinds and Structural Strength Support Sustainable — If Moderating — US Life & Annuity Market Growth

      November 12, 2025

      US Annuity Sales Set Yet Another Quarterly Sales Record in Third Quarter of 2025

      October 30, 2025

      EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

      March 25, 2026

      US Individual Life Insurance New Premium To Set New Sales Record in 2025

      March 4, 2026

      US Life Insurers’ Ample Capital, Liquidity to Support Ratings in 2026

      February 25, 2026

      Higher Sales and Lower Lapse Counts but Rising Exit Values for US Life Insurance Market

      February 11, 2026

      Emergence of Buy-In Deals Supports Third Biggest Year on Record for US Pension Risk Transfer Market

      April 9, 2026
      Lane Clark & Peacock

      2025 Delivers Record Number of Bulk Purchase Annuity Buy-Ins in UK Pension Risk Transfer Market

      March 30, 2026
      Just Group

      Reebok UK Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With M&G

      March 30, 2026

      Athora Group Completes Acquisition of Pension Insurance Corporation

      March 30, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

      March 25, 2026

      Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

      March 25, 2026

      Latest CMI Model Shows Further Rise in Cohort Life Expectancy

      March 11, 2026

      Life Settlement Market Faces Contrasting Views on Term Life Policy Conversions

      April 9, 2026

      Better Mortality Analytics Will Unlock the Next Phase of Life Settlement Growth

      April 9, 2026

      Is the Secondary Life Insurance Market in the UK Set To Re-Emerge?

      April 9, 2026

      Q&A: Brandon Marz, Co-Founder and Chief Strategy Officer, LifeRoc Capital

      March 25, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Life Settlement Market Faces Contrasting Views on Term Life Policy Conversions

      April 9, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Emergence of Buy-In Deals Supports Third Biggest Year on Record for US Pension Risk Transfer Market

      April 9, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    US Individual Life Insurance New Premium To Set New Sales Record in 2025

    Life Insurance March 4, 2026By LMI Newsdesk
    Share
    Twitter LinkedIn Email

    Total new annualised US individual life insurance premium increased 10% year over year to $17.5bn in 2025, according to preliminary results from LIMRA’s individual life insurance sales survey. Individual life insurance new premium has set records for four of the past five years, including 2025. The number of policies sold rose 7% for the year. 

    In the fourth quarter of 2025, new annualised premium totalled $4.9bn, up 6% over the prior year. Policy count rose 9% in the fourth quarter.  

    “It was a remarkable year for individual life insurance. In addition to the favorable economic conditions, advances in technology have improved underwriting automation, digital applications, marketing and lead generation, making the buying process faster and more accessible. These improvements benefit both financial professionals and consumers, reducing friction and expanding distribution reach,” said Sean Grindall, Senior Vice President and Chief Member Relations and Solutions Officer, LIMRA and LOMA.  

    “LIMRA expects economic conditions to weaken in 2026, resulting in overall life insurance new annualised premium to grow between 2% and 6% in 2026. This is slightly above the historical average of 3.1% but well below the double‑digit surge of 2025.” 

    Indexed universal life (IUL) set quarterly and annual sales records. In the fourth quarter, IUL new annualised premium was $1.3bn, up 12% year over year. IUL policy count jumped 13% in the fourth quarter. 

    “IUL sales continue to be a bulwark for the individual life insurance sales market. Expanded distribution, enhanced products and a strong equity market all contributed to the growth for the quarter and in 2025,” said Karen Terry, corporate vice president and head of LIMRA Insurance Research. “Although the economy is slowing, LIMRA is forecasting double-digit IUL sales growth in 2026 as new products are introduced and distribution expands.” 

    For the year, IUL new premium totalled a record-high $4.5bn, 17% higher than 2024 results. Policy sales increased 8% over 2024 levels. 

    IUL new premium represented 25% of the total US life insurance market in 2025. 

    Driven by final expense product sales, total whole life (WL) premium and policy count posted positive growth for the fifth consecutive quarter. WL new premium totalled $1.8bn in the fourth quarter, up 9% year over year. The number of WL policies sold increased 13% in the quarter. 

    “At a time of economic uncertainty, our research suggests consumers look for stable financial investments, like life insurance. A number of companies have expanded their final expense and smaller-face amount business to attract more middle-market consumers,” noted Terry.  

    “While LIMRA expects sales of these products will continue to flourish in 2026. Mutual companies are seeing a shift to universal life products, dampening overall sales.” 

    In 2025, WL new premium climbed 7% to $6.4bn. This sets a new sales record for whole life insurance products. Policy count grew 12% year over year. 

    WL new premium represented 37% of the total life insurance market in 2025. 

    Variable universal life (VUL) new premium totalled $770m in the fourth quarter, down 3%, compared with the fourth quarter 2024 results. The number of policies sold grew 6% in the quarter. 

    For the year, VUL new premium totalled $2.6bn, up 17% year over year. Policy count improved 5%. LIMRA is projecting VUL sales to moderate in 2026, in response to expected equity market volatility.  

    In 2025, VUL held 15% of the total US individual life insurance market. 

    Term life new premium totalled $786m, 5% above fourth quarter 2024 results. Policy count increased 5% in the quarter. Several carriers attribute their growth to rising consumer interest, underwriting automation and expanded distribution. 

    In 2025, term new premium increased 3% year over year to $3.1bn. The number of policies sold grew 2%, compared with 2024 results. LIMRA is forecasting term sales growth to remain relatively flat in 2026. 

    Term life new premium represented 17% of total sales in 2025. 

    Fixed universal life (fixed UL) sales fell for the fifth consecutive quarter. New fixed UL premium contracted 3% in the fourth quarter to $259m. Policy count fell 3% from the prior year results. 

    For the year, fixed UL new premium was $985m, down 4% year over year, and policy count dropped 6%. Fixed UL new premium held 6% of the US life insurance market in 2025. 

    LIMRA’s Retail Individual Life Insurance Sales Survey represents 85% of the US life insurance market. 

    2026 - March News News: March 2026
    Share. Twitter LinkedIn Email

    Related Posts

    Lane Clark & Peacock

    2025 Delivers Record Number of Bulk Purchase Annuity Buy-Ins in UK Pension Risk Transfer Market

    March 30, 2026By LMI Newsdesk
    Just Group

    Reebok UK Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With M&G

    March 30, 2026By LMI Newsdesk

    Athora Group Completes Acquisition of Pension Insurance Corporation

    March 30, 2026By LMI Newsdesk

    Panasonic UK Pension Plan Completes Bulk Purchase Annuity Transaction With M&G

    March 25, 2026By LMI Newsdesk
    Latest Issue

    Life Settlement Market Faces Contrasting Views on Term Life Policy Conversions

    April 9, 2026

    Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

    April 9, 2026

    Emergence of Buy-In Deals Supports Third Biggest Year on Record for US Pension Risk Transfer Market

    April 9, 2026

    Better Mortality Analytics Will Unlock the Next Phase of Life Settlement Growth

    April 9, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.